Compare Novavax Inc (NVAX) vs Omnicom Group Inc. (OMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Omnicom Group Inc. — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Omnicom Group Inc. trades at $79.22 (market cap $23.48B). The key difference: Omnicom Group Inc. is far larger — about 18.1× Novavax Inc's market cap, and Omnicom Group Inc. pays a 3.88% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | OMC | |
|---|---|---|
Market Cap | $1.30B | $23.48B |
Sector | Health | Media |
52-Week High | $11.19 | $85.80 |
52-Week Low | $6.22 | $67.27 |
Enterprise Value | $800.50M | $30.70B |
Dividend Yield | — | 3.88% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →
